A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Multiple-Dose Pharmacokinetics of Ozanimod
Condition(s):Liver Diseases; Digestive System DiseasesLast Updated:June 14, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Liver Diseases; Digestive System DiseasesLast Updated:June 14, 2022Completed
Condition(s):Healthy VolunteersLast Updated:September 20, 2021Completed
Condition(s):Ulcerative ColitisLast Updated:April 18, 2023Not yet recruiting
Condition(s):Healthy VolunteersLast Updated:June 18, 2023Completed
Condition(s):Multiple SclerosisLast Updated:March 27, 2024Not yet recruiting
Condition(s):Colitis, UlcerativeLast Updated:February 2, 2024Recruiting
Condition(s):Healthy VolunteerLast Updated:March 25, 2021Completed
Condition(s):Multiple SclerosisLast Updated:November 15, 2023Active, not recruiting
Condition(s):Crohn DiseaseLast Updated:March 12, 2024Recruiting
Condition(s):Healthy VolunteersLast Updated:February 6, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.